Highlights – SCR

Mothercell Highlights

  • Autologous (patients own) cells taken from bone marrow
  • “Prium Non Nocere“, which means “Not to harm”, as the treatment of any disease should not be more harmful than when leaving it untreated.
  • No profit objective.
  • Unmanipulated Mesenchymal stem cells.
  • Presence of platelet and growth factor rich plasma makes it more effective.
  • Point of care-so no risk of contamination.
  • Cells maximum in no per ml compared to any enrichment tech available.
  • Polyclonal in nature.
  • No risk of rejection.
  • Least side effects.
  • Syringe containg stem cells can be made avaialble for cross verification.
  • Route of administration individualised according to the disorder.
  • Scientificaly monitored by a strict protocol.
  • Ficoll* not used

As per the ICMR guidelines, these are done only as an experimental study